Systemic Lupus Erythematosus News
- Post Roe, New Worries About Meds Linked to Birth Defects
- Roe Reversal May Go Well Beyond Abortion
- Azathioprine Discontinuation Linked to Genotype Regardless of Race
- New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses
- EULAR 2022 Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials
- EULAR 2022 Continuing, Stopping Immunosuppression Tested in Lupus Nephritis
- EULAR 2022 High Maternal, Fetal Morbidity Rates in SLE Pregnancies
- CARRA 2022 Lupus Mutation May Unlock Targeted Drugs for Patient Subset
- EULAR 2022 EULAR Congress Opens New Avenues for Learning, Collaborating
- Abortion Debate May Affect Rx Decisions for Pregnant Women
- Does He Have Back Pain or Rheumatism?
- CARRA 2022 Pfizer COVID Vax Performs Well in Youth With Rheumatic Diseases
- Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial
- Relugolix Combo Eases Long-Neglected Fibroid Symptom: Pain
- Maternal Autoimmune Diseases Up Risk of Mental Illness in Children
- BSR 2022 Lupus May Lead to Worse Stroke Outcomes for Women, but Not Men
- Women in Rheumatology: A Look Back, a Look Forward
- Children With RMDs Not at High Risk for Severe COVID-19
- JIA Disease Activity, Disability Linked to Social Factors
- For the Immunocompromised, COVID Remains a Major Threat